Article info
Clinical and epidemiological research
Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis
- Mirjam K de Vries, VU University Medical Center, Rheumatology Department, Room 3A-64, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands; mk.devries{at}vumc.nl
Citation
Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis
Publication history
- Accepted March 9, 2008
- First published March 28, 2008.
Online issue publication
March 13, 2009
Article Versions
- Previous version (28 March 2008).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 BMJ Publishing Group and European League Against Rheumatism